Wu, L., Xu, W., Li, X., Liu, Y., Wang, L., Zhu, S., . . . Peng, L. (2021). The NTCP p.Ser267Phe Variant Is Associated With a Faster Anti-HBV Effect on First-Line Nucleos(t)ide Analog Treatment. Front Pharmacol.

Wu, Lina, Wenxiong Xu, Xuejun Li, Ying Liu, Lu Wang, Shu Zhu, Fangji Yang, Chan Xie, and Liang Peng. "The NTCP P.Ser267Phe Variant Is Associated With a Faster Anti-HBV Effect On First-Line Nucleos(t)ide Analog Treatment." Front Pharmacol 2021.

Wu, Lina, et al. "The NTCP P.Ser267Phe Variant Is Associated With a Faster Anti-HBV Effect On First-Line Nucleos(t)ide Analog Treatment." Front Pharmacol 2021.